国家医保局：“十四五”医保基金支出12.13万亿，年均增长9.1%

Core Viewpoint - The National Healthcare Security Administration (NHSA) has emphasized the importance of deepening healthcare reform during the "14th Five-Year Plan" period, focusing on the integration of healthcare services with economic and social development [1][2]. Group 1: Healthcare Fund Management - The NHSA has managed a total healthcare fund expenditure of 12.13 trillion yuan, with an average annual growth rate of 9.1% since the beginning of the "14th Five-Year Plan" [2]. - The healthcare fund has significantly supported the pharmaceutical industry, with expenditures on innovative drugs projected to reach 3.9 times the 2020 level by 2024, reflecting an annual growth rate of 40% [2]. Group 2: Reforms and Innovations - The NHSA has implemented a prepayment system for healthcare funds and promoted real-time settlement reforms, covering 357 regions nationwide, with a total of 594.8 billion yuan disbursed since 2025 [1][2]. - The introduction of the "dual directory" reform, including a new commercial health insurance innovative drug directory, aims to support pharmaceutical innovation, with over 100 drugs currently under application [2][3]. Group 3: Integration with Commercial Insurance - The NHSA has facilitated the integration of healthcare insurance with commercial insurance, resulting in over 27 million claims in Shandong province alone benefiting from a "one-stop settlement" service in 2024, enhancing the competitiveness of related insurance products [1][2]. Group 4: Future Directions - The NHSA plans to continue managing healthcare funds effectively while injecting strong momentum into the pharmaceutical industry, aiming to provide more efficient, safe, and accessible medical products and services [3]. - The basic medical insurance coverage rate has remained stable at around 95%, with 1.327 billion people insured in 2024, and annual medical assistance benefiting approximately 8 million people [3].